Updates in Amblyopia Treatment

Host Dr. Andrew Pouw welcomes Drs. Gustavo De Moraes, Aakriti Shukla, and Simon John to discuss their team's work spanning the full arc of nicotinamide as a neuroprotection candidate for glaucoma, from bench to clinical trials. For all episodes or to claim CME credit for selected ...  Show more

Host Dr. Jay Sridhar welcomes Dr. Sarwar Zahid to unpack a recent American Journal of Ophthalmology perspective essay on the growing segment of hospital-employed ophthalmologists. They examine the appeal of the hospitalist model—shift-based work, reduced administrative burden, an ...  Show more

<div class="OutlineElement Ltr SCXW252216131 BCX0">

<span class= "TextRun SCXW252216131 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class= "NormalTextRun SCXW252216131 BCX0">The goal of the</span> <span class="NormalTextR ...

Today, we’re diving into a condition that’s as fascinating as it is complex: Achalasia—where the esophagus stops playing nice, and swallowing becomes a daily challenge.We’re breaking down the latest evidence, comparing POEM, pneumatic dilation, and Heller myotomy, and digging int ...  Show more

New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor ...  Show more

In this episode of the PTJ Podcast, Editor-in-Chief Steven George, PT, PhD, FAPTA, talks with Alexander Garbin, PT, DPT, PhD, and Jennifer Stevens-Lapsley, PT, PhD, FAPTA, about their recently published companion papers, which evaluated the effectiveness of a progressive multi ...